SCHEMBL29681783

SCHEMBL29681783

C[Si](C)(C)CCOCn1c2c(c3c(Cl)ncnc31)-c1noc(C3CC3)c1C(=O)CC2

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21907256 1.00 RET (0.33) RET
SCHEMBL21801387 0.79 RET (0.34) RET
SCHEMBL21801354 0.79 RET (0.39) RET
SCHEMBL29182339 0.78 RET (0.35) RET
SCHEMBL21801443 0.77 RET (0.33) RET
SCHEMBL21908104 0.77 RET (0.43) RET
SCHEMBL21801822 0.76 RET (0.36) RET
SCHEMBL21801379 0.76 RET (0.34) RET
SCHEMBL21801346 0.76 NR1H4 (0.31) RET
SCHEMBL21801510 0.76 RET (0.41) RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3849986-B1 FUSED HETEROCYCLIC COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC (US) 2022-06-08 — — EP disclosed
Send feedback